111 related articles for article (PubMed ID: 6651867)
21. Antitrypanosomal activity of sinefungin.
Dube DK; Mpimbaza G; Allison AC; Lederer E; Rovis L
Am J Trop Med Hyg; 1983 Jan; 32(1):31-3. PubMed ID: 6130709
[TBL] [Abstract][Full Text] [Related]
22. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Trypanosoma brucei brucei peptidyl transferase activity by sparsomycin analogs and effects on trypanosome protein synthesis and proliferation.
Bitonti AJ; Kelly SE; Flynn GA; McCann PP
Biochem Pharmacol; 1985 Sep; 34(17):3055-60. PubMed ID: 4038323
[TBL] [Abstract][Full Text] [Related]
24. 9-(2'-Deoxy-2'-Fluoro-β-d-Arabinofuranosyl) Adenine Is a Potent Antitrypanosomal Adenosine Analogue That Circumvents Transport-Related Drug Resistance.
Ranjbarian F; Vodnala M; Alzahrani KJH; Ebiloma GU; de Koning HP; Hofer A
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373184
[TBL] [Abstract][Full Text] [Related]
25. Bistacrines as potential antitrypanosomal agents.
Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of the trypanocidal diamidine DAPI on animal-infective Trypanosoma brucei brucei.
Borowy NK; Fink E; Hirumi H
Acta Trop; 1985 Dec; 42(4):287-98. PubMed ID: 2868631
[TBL] [Abstract][Full Text] [Related]
27. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of carnitine acetyltransferase by metabolites of 4-pentenoic acid.
Zhong J; Fong JC; Schulz H
Arch Biochem Biophys; 1985 Aug; 240(2):524-9. PubMed ID: 4026294
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of the antitrypanosomal activity of peptidyl alpha-aminoalkyl phosphonate diphenyl esters.
Morty RE; Troeberg L; Powers JC; Ono S; Lonsdale-Eccles JD; Coetzer TH
Biochem Pharmacol; 2000 Nov; 60(10):1497-504. PubMed ID: 11020452
[TBL] [Abstract][Full Text] [Related]
30. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
[TBL] [Abstract][Full Text] [Related]
31. Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads.
Jain S; Jacob M; Walker L; Tekwani B
BMC Complement Altern Med; 2016 May; 16():131. PubMed ID: 27193901
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glyceraldehyde-3-phosphate dehydrogenase by pentalenolactone in Trypanosoma brucei.
Duszenko M; Mecke D
Mol Biochem Parasitol; 1986 Jun; 19(3):223-9. PubMed ID: 3736593
[TBL] [Abstract][Full Text] [Related]
33. Antitrypanosomal properties of cis-platinum-pentamidine bromide, thiocyanate and seleniocyanate on Trypanosoma brucei brucei mouse and sheep models.
Loiseau PM; Dreyfuss G; Doadrio L; Parrondo E; Craciunescu DG
J Chemother; 2001 Feb; 13(1):59-65. PubMed ID: 11233802
[TBL] [Abstract][Full Text] [Related]
34. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
Hannaert V
Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
[TBL] [Abstract][Full Text] [Related]
35. In vitro antitrypanosomal activity of the cyclodepsipeptides, cardinalisamides A-C, from the insect pathogenic fungus Cordyceps cardinalis NBRC 103832.
Umeyama A; Takahashi K; Grudniewska A; Shimizu M; Hayashi S; Kato M; Okamoto Y; Suenaga M; Ban S; Kumada T; Ishiyama A; Iwatsuki M; Otoguro K; Omura S; Hashimoto T
J Antibiot (Tokyo); 2014 Feb; 67(2):163-6. PubMed ID: 24084682
[TBL] [Abstract][Full Text] [Related]
36. New heterocyclic compounds: Synthesis and antitrypanosomal properties.
Pomel S; Dubar F; Forge D; Loiseau PM; Biot C
Bioorg Med Chem; 2015 Aug; 23(16):5168-74. PubMed ID: 25835356
[TBL] [Abstract][Full Text] [Related]
37. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
[TBL] [Abstract][Full Text] [Related]
38. Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-phe-ala-CHN2.
Scory S; Caffrey CR; Stierhof YD; Ruppel A; Steverding D
Exp Parasitol; 1999 Apr; 91(4):327-33. PubMed ID: 10092476
[TBL] [Abstract][Full Text] [Related]
39. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
Bouteille B; Darde ML; Pestre-Alexandre M
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
